Full-length recombinant human SETD4 was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag.
Catalog No. S353-30G
| Catalog No. | Pack Size | Price (USD) | |
|---|---|---|---|
| S353-30G-20 | 20 ug | $314 | |
| S353-30G-50 | 50 ug | $545 | |
| S353-30G-BULK | BULK | Contact Us |
Overview:
SET domain-containing protein 4 (SETD4) is a lysine methyltransferases that plays a crucial role in breast carcinogenesis. A correlation between high expression of SETD4 and a lack of the estrogen receptor (ER) in breast cancer was identified. SETD4 up-regulation is also associated with the proliferation of breast cancer cell line.
Gene Aliases:
C21orf18, C21orf27
Genbank Number:
References:
1. Faria JA, et al: SET domain-containingProtein 4 (SETD4) is a Newly Identified Cytosolic and Nuclear Lysine Methyl-transferase involved in Breast Cancer Cell Proliferation. J Cancer Sci Ther. 2013 5(2):58-65.
Purity:
Sample Purity Data. For specific information on a given lot, see related technical data sheet.
|
Storage, Stability, and Shipping:
Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
Molecular Weight:
~62 kDa
There are no related publications available for this product.
Apoptosis/Autophagy, Cancer, Cell Cycle, Neurobiology
STAY CONNECTED
Fax: 1-604-232-4601
Toll Free: 1-866-954-6273
info@signalchem.com